Alerts will be sent to your verified email
Verify EmailMADHUDIN
|
Madhusudan Inds
|
Dipna Pharma.
|
Regent Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.65 % | 16.1 % | 1.5 % |
|
5yr average Equity Multiplier
|
1.29 | 14.87 | 1.7 |
|
5yr Average Asset Turnover Ratio
|
0.06 | 1.35 | 10.36 |
|
5yr Avg Net Profit Margin
|
40.18 % | 0.81 % | 0.04 % |
|
Price to Book
|
0.68 | 0.34 | 0.47 |
|
P/E
|
0.0 | 20.03 | 4.87 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -33.62 Days | 14.09 Days |
|
Inventory Days
|
24.22 Days | 62.45 Days | 7.81 Days |
|
Days Receivable
|
739.65 Days | 112.8 Days | 16.56 Days |
|
Days Payable
|
88.75 Days | 139.84 Days | 14.56 Days |
|
5yr Average Interest Coverage Ratio
|
3.87 | 2.01 | 1.88 |
|
5yr Avg ROCE
|
4.59 % | 12.33 % | 2.54 % |
|
5yr Avg Operating Profit Margin
|
-32.0 % | 2.41 % | -0.04 % |
|
5 yr average Debt to Equity
|
0.17 | 5.84 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 117.34 % | n/a |
|
5yr Average Return on Assets
|
2.77 % | 1.21 % | 0.52 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.08 % | 9.13 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -57.43 % | -1.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.01 % | 0.0 | 0.0 |
|
Madhusudan Inds
|
Dipna Pharma.
|
Regent Enterprises
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|